Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Treasury Shares came in at $671147.0 in Q1 2026, up 121.2% year-on-year from $303417.0 in Q1 2025, and up 92.31% on a QoQ basis from $348994.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 3 years of Treasury Shares data on file, last reported at $671147.0 in Q1 2026.
- On a quarterly basis, Treasury Shares rose 121.2% year-over-year to $671147.0 in Q1 2026; TTM through Mar 2026 was $671147.0, a 121.2% increase from a year earlier, with the FY2025 full-year figure at $348994.0, up 66.19% from the prior year.
- Treasury Shares for Q1 2026 stood at $671147.0, up from $348994.0 in the prior quarter.
- Over the last five years, Treasury Shares for XENE reached as high as $671147.0 in Q1 2026 and fell as low as $192000.0 in Q1 2024.
- Historically, Treasury Shares has averaged $306766.3 across 3 years, with a median of $303417.0 in 2025.
- Across the five-year window, Treasury Shares surged 49.23% in 2025 and jumped 121.2% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $210000.0 in 2024, then surged by 66.19% to $348994.0 in 2025, then jumped by 92.31% to $671147.0 in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $671147.0 in Q1 2026, $348994.0 in Q4 2025, and $313382.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | 671,147.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 671,147.00 |
| Mar 31, 2026 | 671,147.00 |
| Dec 31, 2025 | 348,994.00 |
| Dec 31, 2025 | 348,994.00 |
| Sep 30, 2025 | 313,382.00 |
| Sep 30, 2025 | 313,382.00 |
| Jun 30, 2025 | 316,957.00 |
| Jun 30, 2025 | 316,957.00 |
| Mar 31, 2025 | 303,417.00 |
| Mar 31, 2025 | 303,417.00 |
| Dec 31, 2024 | 210,000.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |